NantBioscience's Corporate Minority Round

NantBioscience raised a round of funding on January 13, 2014. Investors include Celgene.

NantBioScience, a wholly-owned subsidiary of NantWorks,,is a biopharmecuetical company focused on the discovery of treatments by developing molecularly targeted drugs, based on the molecular profile o…

Articles about NantBioscience's Corporate Minority Round: